Summit outcomes and next steps
On 15th March, EuropaBio hosted its first Biomanufacturing Policy Summit in Brussels, with the aim of setting the vision for Europe’s global innovation, competitiveness, and sustainability on biomanufacturing, while raising awareness among policy-makers. The Summit established a starting point, a first step for a long journey that needs to be traveled by all stakeholders in Europe – SMEs, large companies, expert services, and EU institutions – and which has already started in other parts of the world.
80 attendees from industry, national associations, and stakeholders across the public and private spectrum presented, debated, and proposed. In a fast-moving industrial transition, calls for visionary policies, enabling regulation, and urgent action were some of the key takeaways from the summit. You can see the March 15th Summit agenda here.
Would you like to find out more?
Join us on April 27 between 14:00 – 15:15 CET for a summit presentation and follow-up and add your voice to the discussion. This webinar will wrap up the main outcomes of the summit and lay the groundwork for future discussions.
Biomanufacturing is key to the digital and green transitions and to securing a competitive and resilient future for Europe. Stay tuned for Europe’s future in biomanufacturing!
14:00: Welcome and introduction – Claire Skentelbery, Director General, EuropaBio
14:10: Biomanufacturing Policy Summit report presentation – Virginia Claudio, Sr Adviser & Programme Manager, EuropaBio
The report presentation summarises the summit outcomes and builds policy recommendations for the development of the Biomanufacturing landscape in Europe.
14:20: Report perspectives & reflections from healthcare and biotech industries, and national associations – Sarah Moundir, EU Public Affairs Senior Manager, Novartis | Gwenael Servant, Board Executive, Abolis | Inga Matijosyte, Vice President, LithuaniaBIO
A diverse group of stakeholders representing the wide spectrum of Biomanufacturing shares their views over the report outcomes, as well as the priorities for their companies and organisations.
14:50: Discussion and Q&A with the audience
A discussion based on questions from the audience with a focus on the next steps for policy making on Biomanufacturing.
15:10: Close – Closing remarks.